ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOEL COHEN M.D.

Psychiatry

8,775

$1.37M

389
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$157
Average prescription price

Avg: $160

ANGIOLINA MELCHIORRE M.D.

Psychiatry

5,338

$1.04M

284
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$195
Average prescription price

Avg: $160

ROBERT KEISLING M.D.

Psychiatry

3,944

$721K

119
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$183
Average prescription price

Avg: $160

RISA FISHMAN MD

Psychiatry

3,163

$349K

205
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$110
Average prescription price

Avg: $160

JEAN D'SOUZA M.D.

Psychiatry

2,328

$302K

210
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$130
Average prescription price

Avg: $160

DANIEL PODELL M.D.

Psychiatry

2,192

$316K

157
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$144
Average prescription price

Avg: $160

MICHELLE BROADNAX M.D.

Psychiatry

2,173

$393K

124
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$181
Average prescription price

Avg: $160

STEPHEN PETERSON MD

Psychiatry

1,845

$208K

179
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $160

ASIM HARACIC MD

Psychiatry

1,793

$192K

134
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$107
Average prescription price

Avg: $160

DAVID AULT M.D.

Psychiatry

1,671

$288K

102
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$172
Average prescription price

Avg: $160

ROBBYN TUREMAN

Psychiatry

1,632

$266K

84
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$163
Average prescription price

Avg: $160

NI NI KHIN MD

Psychiatry

1,589

$270K

120
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$170
Average prescription price

Avg: $160

MARINA BOTA MD

Psychiatry

1,479

$189K

65
0 are 65+

20%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$128
Average prescription price

Avg: $160

RONALD KOSHES MD

Psychiatry

1,471

$367K

138
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$250
Average prescription price

Avg: $160

MELVIN WILLIAMS M.D.

Psychiatry

1,339

$297K

97
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$222
Average prescription price

Avg: $160

IGOR VOLKOV M.D.

Psychiatry

1,177

$284K

78
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$241
Average prescription price

Avg: $160

BRINDA KRISHNAN M.D.,

Psychiatry

1,148

$284K

79
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$248
Average prescription price

Avg: $160

YVONNE BASCUG M.D.

Psychiatry

1,130

$150K

85
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

27%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$133
Average prescription price

Avg: $160

ROBERT KETCHAM MD

Psychiatry

950

$138K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$145
Average prescription price

Avg: $160

JULIAN REDDITT M.D.

Psychiatry

930

$230K

64
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$247
Average prescription price

Avg: $160

CHRISTINE LEPOUTRE M.D.

Psychiatry

923

$36.7K

114
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 27%

$40
Average prescription price

Avg: $160

PAUL DELLEMONACHE MD

Psychiatry

920

$57.8K

91
47 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $160

MARGARET ROBERTS M.D.

Psychiatry

903

$169K

97
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$187
Average prescription price

Avg: $160

VENKATESH HANDRATTA M.D.

Psychiatry

899

$165K

66
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 27%

$184
Average prescription price

Avg: $160

BEVERLY READER M.D.

Psychiatry

724

$131K

63
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$181
Average prescription price

Avg: $160

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank